Roger Ferrini

Roger Ferrini, PhD, PMP, RAC-Drugs, currently serves as the Associate Director of Program Management at Skye Bioscience Inc. since June 2025. Previously, Roger held roles as Associate Director of Development at IgGenix, Inc., and as Sr Project Manager at Sentynl Therapeutics, Inc. With a strong background in program management and technical oversight in antibody technologies, Roger has successfully led various development programs and managed collaborations in drug discovery, notably at Bird Rock Bio, Inc. where Roger was the Head of Antibody Technologies. Roger's academic credentials include a PhD in Immunology from UCLA and a postdoctoral fellowship at Harvard Medical School.